Correlation Between ATT and Apellis Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both ATT and Apellis Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ATT and Apellis Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ATT Inc and Apellis Pharmaceuticals, you can compare the effects of market volatilities on ATT and Apellis Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ATT with a short position of Apellis Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of ATT and Apellis Pharmaceuticals.
Diversification Opportunities for ATT and Apellis Pharmaceuticals
-0.76 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between ATT and Apellis is -0.76. Overlapping area represents the amount of risk that can be diversified away by holding ATT Inc and Apellis Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Apellis Pharmaceuticals and ATT is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ATT Inc are associated (or correlated) with Apellis Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Apellis Pharmaceuticals has no effect on the direction of ATT i.e., ATT and Apellis Pharmaceuticals go up and down completely randomly.
Pair Corralation between ATT and Apellis Pharmaceuticals
Taking into account the 90-day investment horizon ATT is expected to generate 3.83 times less return on investment than Apellis Pharmaceuticals. But when comparing it to its historical volatility, ATT Inc is 3.86 times less risky than Apellis Pharmaceuticals. It trades about 0.19 of its potential returns per unit of risk. Apellis Pharmaceuticals is currently generating about 0.19 of returns per unit of risk over similar time horizon. If you would invest 2,734 in Apellis Pharmaceuticals on August 28, 2024 and sell it today you would earn a total of 457.00 from holding Apellis Pharmaceuticals or generate 16.72% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
ATT Inc vs. Apellis Pharmaceuticals
Performance |
| Timeline |
| ATT Inc |
| Apellis Pharmaceuticals |
ATT and Apellis Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with ATT and Apellis Pharmaceuticals
The main advantage of trading using opposite ATT and Apellis Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ATT position performs unexpectedly, Apellis Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apellis Pharmaceuticals will offset losses from the drop in Apellis Pharmaceuticals' long position.The idea behind ATT Inc and Apellis Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Apellis Pharmaceuticals vs. Eliem Therapeutics | Apellis Pharmaceuticals vs. HCW Biologics | Apellis Pharmaceuticals vs. Scpharmaceuticals | Apellis Pharmaceuticals vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Other Complementary Tools
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |